Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active agents. Its structure supports the design of compounds targeting neurological disorders, including antidepressants and antipsychotics. The cyclopropyl group enhances metabolic stability and binding affinity in drug molecules. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its conformational rigidity and bioavailability enhancement properties. Also utilized in the preparation of receptor modulators, especially for GPCR-targeted drugs.